CAS 1055027-48-9

Formula: C10H13N3O5

InChI: InChI=1S/C10H13N3O5/c14-4-7(15)9(17)8(16)6-3-11-10(12-6)5-1-2-18-13-5/h1-3,7-9,14-17H,4H2,(H,11,12)/t7-,8-,9-/m1/s1

InChI key: WGDPRIZUIYIENM-IWSPIJDZSA-N

SMILES: C1=CON=C1C2=NC=C(N2)[C@H]([C@@H]([C@@H](CO)O)O)O

(1R,2S,3R)-1-(2-(Isoxazol-3-yl)-1H-imidazol-5-yl)butane-1,2,3,4-tetraol

CAS: 1055027-48-9

Formula: C₁₀H₁₃N₃O₅

Molecular weight: 255.2273

Ref: IN-DA009MBO

(1R,2S,3R)-1-(2-(Isoxazol-3-yl)-1H-imidazol-5-yl)butane-1,2,3,4-tetraol

CAS: 1055027-48-9

(1R,2S,3R)-1-(2-(Isoxazol-3-yl)-1H-imidazol-5-yl)butane-1,2,3,4-tetraol is a hydrating agent that is used to maintain the moisture of the skin. It can be used in cosmetics or personal care products to prevent drying and flaking of the skin. (1R,2S,3R)-1-(2-(Isoxazol-3-yl)-1H-imidazol-5-yl)butane-1,2,3,4-tetraol has been shown to increase water content on the surface of the skin and improve dryness by increasing hydration.

Formula: C₁₀H₁₃N₃O₅

Purity: Min. 95%

Molecular weight: 255.23 g/mol

Ref: 3D-FSB02748

LX2932

CAS: 1055027-48-9

LX2932 is an oral analog of LX2931 and acts as a modulator of the S1P/S1PR signaling pathway. It effectively decreases the number of circulating lymphocytes in a dose-dependent manner. Additionally, LX2932 has been shown to ameliorate collagen-induced arthritis.

Formula: C₁₀H₁₃N₃O₅

Molecular weight: 255.23

Ref: TM-T214664